Vaxigrip, suspension injectable

7680700510066 CH-70051 Injektionssuspension

No image available

Article details

Package size
10
Selling units
10
Measure
Fertigspritze(n)
Galenic form
Injektionssuspension
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
18/07/2026
Summary of Product Characteristics
Français
18/07/2026
Summary of Product Characteristics
Italien
18/07/2026

Detailed composition

Substance Quantity Type Category
haemagglutininum influenzae A (H1N1)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae A (H3N2)
15.0 UG Substance Wirkstoff (Principe actif)
haemagglutininum influenzae B
15.0 UG Substance Wirkstoff (Principe actif)
natrii chloridum
- Substance HNIDK
kalii chloridum
- Substance HNIDK
dinatrii phosphas dihydricus
- Substance HNIDK
kalii dihydrogenophosphas
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
1.72 MG Substance HBESI
kalium
0.08 MG Substance HBESI
formaldehydum
- Substance RESI
octoxinolum-9
- Substance RESI
ovalbuminum
- Substance RESI
neomycinum
- Substance RESI

Authorization holder

Sanofi-Aventis (Suisse) SA

1214 Vernier

Authorization information

Swissmedic authorization number
70051
Drug name
Vaxigrip, suspension injectable
Galenic form
SUPAS
ATC Code
J07BB02
Authorization status
Z
Dispensing category
B
First authorization
06/05/2025
Authorization expiration date
05/05/2030
IT Number
08.08.
Domain
Human medicine

Package details

Description (FR)
VAXIGRIP susp inj 2026/2027 10 ser pré 0.5 ml
Description (DE)
VAXIGRIP Inj Susp 2026/2027 10 Fertspr 0.5 ml
Market launch
07/09/2026
Narcotic (BTM)
No

Other package sizes (5)

None
1 FESP
GTIN: None
Not in V1
None
10 FESP
GTIN: None
Not in V1
VAXIGRIP susp inj 15 µg 1 pce
1 FESP
GTIN: 7680700510035
View
None
10 FESP
GTIN: None
Not in V1
VAXIGRIP susp inj 2026/2027 ser pré 0.5 ml
1 FESP
GTIN: 7680700510059
View
Buy us a coffee Explore the data